DiscoverCME in Minutes: Education in Primary CareAlice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes
Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes

Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes

Update: 2025-09-30
Share

Description

Please visit answersincme.com/AVD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, three experts in diabetes discuss approved and emerging once-weekly insulin analogs. Upon completion of this activity, participants should be better able to: Identify patients with T2D who may benefit from basal insulin therapy, including those suited for once-weekly formulations; Assess the clinical data of approved and emerging once-weekly basal insulin analogs; Evaluate opportunities and challenges associated with once-weekly basal insulin therapy.
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes

Alice YY Cheng, MD, FRCPC / Jill Trinacty, MD, FRCPC, ABOM / Bruce A. Perkins, MD, MPH - From Daily to Weekly: Advancing the Basal Insulin Landscape for Type 2 Diabetes

Answers in CME